Dimensional Fund Advisors
YTEN

Dimensional Fund Advisors’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Dimensional Fund Advisors’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-987
Closed -$202K – 3543
2021
Q2 		$202K Buy
+987
New +$220K ﹤0.01% 3333
2014
Q3 		– Hold
0
– -$9K – 3568
2014
Q2 		– Hold
0
– – – 3542
2014
Q1 		– Hold
0
– – – 3508
2013
Q4 		– Hold
0
– – – 3468
2013
Q3 		– Hold
0
– – – 3491
2013
Q2 		– Hold
0
– – – 3473

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Dimensional Fund Advisors's YTEN Position: Q3 2021 in Review

Dimensional Fund Advisors sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2021, closing a stake of 987 shares — an estimated $202K sold.

Dimensional Fund Advisors first reported a position in YTEN in Q2 2021 and held it in 1 quarter. The position peaked at $202K in Q2 2021. 13 funds tracked by Wall St. Rank hold YTEN as of Q3 2021.

  • Dimensional Fund Advisors reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 987 Yield10 Bioscience, Inc. Common Stock shares in Q3 2021, an estimated $202K.
  • Dimensional Fund Advisors first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Dimensional Fund Advisors's Yield10 Bioscience, Inc. Common Stock position peaked at $202K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2021.

Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.